FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

8070211000001106: Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1584881000001113 Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1584891000001110 Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
29385501000001110 Sativex oromucosal spray (GW Pharmaceuticals Ltd) 102 dose 2 x 51 doses (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
29385601000001114 Sativex oromucosal spray (GW Pharmaceuticals Ltd) 102 dose 2 x 51 doses en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
41782201000001113 Sativex oromucosal spray (GW Pharmaceuticals Plc) 102 dose 2 x 51 doses en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
43165001000001113 Sativex oromucosal spray (Imported (Canada)) 102 dose 2 x 51 doses en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
51978101000001111 Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
75699201000001115 Sativex oromucosal spray (Bayer Plc) 102 dose 2 x 51 doses en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 4 (CD Benz) true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses Is a Delta-9-tetrahydrocannabiol 2.92mg/actuation / Cannabidiol 2.7mg/actuation oromucosal spray 102 dose true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses Is pack of Sativex oromucosal spray (GW Pharma Ltd) false Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses Has active ingredient Cannabidiol false Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses Has active ingredient Tetrahydrocannabinol false Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses Has active ingredient Dronabinol false Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses Has manufactured dose form Spray dose form false Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses Has AMP Sativex oromucosal spray (GW Pharma Ltd) true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses Has specific active ingredient Dronabinol true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses Has specific active ingredient Cannabidiol true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses Has dispensed dose form Spray dose form true Inferred relationship Existential restriction modifier
Sativex oromucosal spray (GW Pharma Ltd) 102 dose 2 x 51 doses Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start